LF
ELV icon

Lansforsakringar Fondforvaltning’s Elevance Health ELV Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2M Sell
70,230
-4,048
-5% -$1.5M 0.12% 131
2026
Q1 		$21.7M Buy
74,278
+968
+1% +$318K 0.11% 159
2025
Q4 		$25.7M Buy
73,310
+696
+1% +$235K 0.13% 137
2025
Q3 		$23.5M Buy
72,614
+2,280
+3% +$709K 0.12% 144
2025
Q2 		$27.4M Sell
70,334
-5,178
-7% -$2.08M 0.16% 117
2025
Q1 		$32.8M Sell
75,512
-2,902
-4% -$1.16M 0.2% 99
2024
Q4 		$28.9M Buy
+78,414
New +$32.8M 0.16% 113

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lansforsakringar Fondforvaltning's ELV Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Elevance Health (ELV) stake by 5.4% in Q2 2026, selling an estimated $1.5M and leaving 70,230 shares worth $27.2M. The position accounts for 0.12% of the portfolio, ranked #131.

Lansforsakringar Fondforvaltning first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $32.8M in Q1 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 70,230 shares of Elevance Health worth $27.2M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 4,048 Elevance Health shares in Q2 2026, an estimated $1.5M.
  • Elevance Health made up 0.12% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #131 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Lansforsakringar Fondforvaltning's Elevance Health position peaked at $32.8M in Q1 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.